IP Library Assignment 027094/0001
Patent Assignment
Reel/Frame 027094/0001

Assignment of Assignor's Interest

Recorded: 2011-10-20 Pages: 27
Assignor
3M INNOVATIVE PROPERTIES COMPANY
Executed: 2006-12-20
Assignee
GRACEWAY PHARMACEUTICALS LLC
340 EDGEMONT AVENUE, SUITE 500, BRISTOL, TENNESSEE, 37620
Covered Property (1)
Treatment for Basal Cell Carcinoma
Patent: 8,835,394 →
Application: 13/276,068 →
Publication: US 2012/0035205
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 20, 2011
From: OWENS, MARY L.; FOX, TERRANCE L.; GINKEL, ANGELA M.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 027093/0928 →
Security Agreement Apr 24, 2013
From: MEDICIS PHARMACEUTICAL CORPORATION
To: GOLDMAN SACHS LENDING PARTNERS LLC
Reel/Frame 030281/0433 →
Notice of Succession of Agency Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
Release of Security Interest Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →